ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 380 in its research report dated February 01, 2017.
HDFC Securities is bullish on Cadila has recommended buy rating on the stock with a target price of Rs 385 in its research report dated January 31, 2017.
Karvy recommended hold rating on Cadila Healthcare with a target price of Rs 392 in its research report dated February 01, 2017.
KR Choksey is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 410 in its research report dated February 01, 2017.
Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 425 in its research report dated January 31, 2017.
Axis Direct has recommended hold rating on Cadila Healthcare with a target price of Rs 350 in its research report dated August 05, 2016.
Religare is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 370 in its research report dated August 03, 2016.
Edelweiss has recommended hold rating on Cadila Healthcare with a target price of Rs 315 in its research report dated August 04, 2016.
Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 400 in its research report dated August 03, 2016.
KRChoksey is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 365 in its research report dated January 12, 2016.
Sharekhan has come out with its report on top stocks picks. Ashok Leyland, Bajaj Finance, Britannia Industries, Cadila Healthcare, Dr. Reddy‘s Lab, IndusInd Bank, Maruti Suzuki Relaxo Footwear, Reliance Industries, SBI, TCS and Zee Entertainment are amongst the list.
Sharekhan is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 515 in its October 23, 2015 research report.
ICICI Direct is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 510 in its October 23, 2015 research report.
Brokerage house Firstcall Research is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 2200 in its research report dated August 31, 2015.
Angel Broking has maintained a neutral rating on Cadila Healthcare, in its research report dated August 18, 2015.
Brokerage house KRChoksey has recommended a hold rating on Cadila Healthcare with a target price of Rs 2105 per share in its research report dated August 12, 2015.
Brokerage house Firstcall Research is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 1920 in its research report dated May 18, 2015.
ICICIdirect.com has recommended to buy Cadila Healthcare in the range of Rs 1595-1625 for a target of Rs 1870 with a stop loss below Rs 1490, in its research report dated March 17, 2015.
Brokerage house Sharekhan is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 2060 in its research report dated March 23, 2015.
Brokerage house Firstcall Research is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 1727 in its research report dated February 12, 2015.
Angel Broking has maintained a neutral rating on Cadila Healthcare, in its February 16, 2015 research report.
KRChoksey is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target price of Rs 1736 in its research report dated February 10, 2015.
Brokerage house Firstcall Research is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 1715 in its research report dated December 18, 2014.
KRChoksey is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target price of Rs 1480 in its November 07, 2014 research report.
Angel Broking is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 1080 in its May 19, 2014 research report.